23andMe cuts 40% of its workforce, discontinues all therapy programs | CNN Business

CNN  — 

Genetic testing firm 23andMe said on Monday it is reducing about 40%, or 200 employees, from its workforce and discontinuing further development of all its therapies as part of a restructuring program.

“We are taking these difficult but necessary actions as we restructure 23andMe and focus on the long-term success of our core consumer business and research partnerships,” said CEO Anne Wojcicki.

The company said it is evaluating strategic alternatives, including licensing agreements and asset sales, for its therapies in development.

Wojcicki, who has been trying to take the company

→ Continue reading at CNN - Business News

More from author

Related posts

Advertisment

Latest posts

Chris Wallace departs CNN after three years at network | CNN Business

New York CNN  —  Chris Wallace, the veteran journalist who has anchored weekly programs on CNN and the Max...

Why One Prominent Investor, ‘Britain’s Warren Buffett,’ Is Staying Away From Nvidia Stock

While some strategists say to "buy high, sell higher" on Nvidia stock, Terry Smith is staying away from Nvidia altogether.Smith has been called Britain's...

How Much Do Tesla Employees Make? Internal Docs Reveal the Surprising Salaries of Elon Musk’s ‘Hardcore’ Staffers.

Elon Musk still wants "hardcore" workers, and it's not just at X.Landing a job at Tesla, where Musk is CEO, can be a difficult...